U.S. files first charges in generic drug price-fixing probe: Bbg

(Reuters) - The U.S. Department of Justice accused two executives of Heritage Pharmaceuticals Inc of colluding with other generic drugmakers to fix prices, the first criminal charges stemming from a sweeping two-year investigation, Bloomberg reported.